184 related articles for article (PubMed ID: 12368635)
1. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation.
Haynes JC; Machtay M; Weber RS; Weinstein GS; Chalian AA; Rosenthal DI
Laryngoscope; 2002 Oct; 112(10):1883-7. PubMed ID: 12368635
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
6. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
Veness MJ; Morgan GJ; Palme CE; Gebski V
Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
[TBL] [Abstract][Full Text] [Related]
7. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
[TBL] [Abstract][Full Text] [Related]
9. CHART revisited: a conservative approach for advanced head and neck cancer.
Saunders M; Rojas AM; Dische S
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
12. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
13. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
14. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
15. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
18. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
19. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Jonkman A; Kaanders JH; Terhaard CH; Hoebers FJ; van den Ende PL; Wijers OB; Verhoef LC; de Jong MA; Leemans CR; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):119-25. PubMed ID: 17448870
[TBL] [Abstract][Full Text] [Related]
20. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
